Ex­clu­sive: CRISPR de­liv­ery start­up, based on UC Berke­ley and UCSF sci­ence, shuts down

Spot­light Ther­a­peu­tics, a start­up with a bold vi­sion for de­liv­er­ing CRISPR ther­a­pies in­to the body with­out the need for vi­ral vec­tors or lipid nanopar­ti­cles, has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER